adenosine monophosphate has been researched along with Cardiomyopathy, Dilated in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Saffar, F; Cruz, D; Fan, A; Gaynor, P; Hsu, JJ; Kamath, M; Nsair, A | 1 |
| Miyamoto, SD; Nakano, SJ; Nelson, P; Sucharov, CC | 1 |
| Hintze, T; Jacobson, KA; Kumar, TS; Liang, BT; Mamdani, M; Pappano, AJ; Qanud, K; Recchia, FA; Shen, JB; Zhou, SY | 1 |
| Arbustini, E; Pasotti, M; Repetto, A; Tavazzi, L | 1 |
| Feldman, AM; McNamara, DM; Wagner, DR | 1 |
| DeNofrio, D; Holmes, EW; Loh, E; Mahoney, PD; Rebbeck, TR; Swain, JL | 1 |
| Fleck, E; Regitz, V | 1 |
| Bianco, R; Einzig, S; Foker, J; Noren, G; St Cyr, J; Staley, N; Wang, TC | 1 |
1 review(s) available for adenosine monophosphate and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Genetic predisposition to heart failure.
Topics: Adenosine Monophosphate; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Carrier Proteins; Consanguinity; Cytokines; Cytoskeletal Proteins; Effect Modifier, Epidemiologic; Endothelins; Gene Pool; Genetic Predisposition to Disease; Genetic Variation; Growth Substances; Heart Failure; Humans; Matrix Metalloproteinases; Models, Genetic; Molecular Epidemiology; Muscle Proteins; Nitric Oxide; Oxidative Stress; Phenotype; Polymorphism, Genetic; Receptors, Adrenergic; Renin-Angiotensin System | 2004 |
7 other study(ies) available for adenosine monophosphate and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
COVID-19 in a high-risk dual heart and kidney transplant recipient.
Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Cardiomyopathy, Dilated; Coronavirus Infections; COVID-19; Heart Transplantation; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Pandemics; Pneumonia, Viral; Radiography, Thoracic; Randomized Controlled Trials as Topic; Risk Factors; SARS-CoV-2; Treatment Outcome | 2020 |
Myocardial Response to Milrinone in Single Right Ventricle Heart Disease.
Topics: Adenosine Monophosphate; Calcium-Binding Proteins; Cardiomyopathy, Dilated; Child; Child, Preschool; Female; Heart Transplantation; Heart Ventricles; Humans; Infant; Male; Milrinone; Myocardium; Phosphodiesterase 3 Inhibitors; Phosphoric Diester Hydrolases | 2016 |
Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptors.
Topics: Adenosine Monophosphate; Animals; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Dogs; Heart; Heart Failure; Heart Function Tests; Hemodynamics; Infusions, Intravenous; Male; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Receptors, Purinergic P2; Tachycardia; Ultrasonography; Ventricular Function, Left | 2010 |
AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression.
Topics: Adenosine; Adenosine Monophosphate; Alleles; AMP Deaminase; Cardiomyopathy, Dilated; Disease Progression; Energy Metabolism; Genetic Predisposition to Disease; Genotype; Heart Failure; Humans; Myocardium; Receptors, Purinergic P1 | 1999 |
Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
Topics: Adenosine Monophosphate; Aged; Alleles; AMP Deaminase; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Coronary Disease; Digoxin; Disease Progression; Diuretics; DNA Mutational Analysis; Energy Metabolism; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Phenotype; Proportional Hazards Models; Survival Analysis; Treatment Outcome | 1999 |
Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Cardiac Output; Cardiac Output, Low; Cardiomyopathy, Dilated; Coronary Disease; Energy Metabolism; Heart Failure; Humans; Myocardium; Norepinephrine | 1992 |
Myocardial high-energy phosphate levels in cardiomyopathic turkeys.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiomyopathy, Dilated; Disease Models, Animal; Myocardium; Phosphocreatine; Turkeys | 1986 |